Auna (AUNA) Competitors

$8.55
-0.22 (-2.51%)
(As of 05:32 PM ET)

AUNA vs. LFMD, TVTX, EHAB, TSHA, OFIX, VYGR, WGS, FULC, KALV, and ALEC

Should you be buying Auna stock or one of its competitors? The main competitors of Auna include LifeMD (LFMD), Travere Therapeutics (TVTX), Enhabit (EHAB), Taysha Gene Therapies (TSHA), Orthofix Medical (OFIX), Voyager Therapeutics (VYGR), GeneDx (WGS), Fulcrum Therapeutics (FULC), KalVista Pharmaceuticals (KALV), and Alector (ALEC). These companies are all part of the "medical" sector.

Auna vs.

Auna (NYSE:AUNA) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, community ranking, risk and dividends.

Auna has a net margin of 0.00% compared to LifeMD's net margin of -14.75%.

Company Net Margins Return on Equity Return on Assets
AunaN/A N/A N/A
LifeMD -14.75%N/A -49.23%

Auna has higher earnings, but lower revenue than LifeMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AunaN/AN/AN/AN/AN/A
LifeMD$152.55M2.36-$20.60M-$0.74-11.53

LifeMD received 22 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 70.27% of users gave LifeMD an outperform vote.

CompanyUnderperformOutperform
AunaOutperform Votes
4
100.00%
Underperform Votes
No Votes
LifeMDOutperform Votes
26
70.27%
Underperform Votes
11
29.73%

Auna currently has a consensus target price of $14.15, indicating a potential upside of 61.99%. LifeMD has a consensus target price of $11.60, indicating a potential upside of 39.59%. Given Auna's higher possible upside, equities research analysts clearly believe Auna is more favorable than LifeMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
LifeMD
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, LifeMD had 9 more articles in the media than Auna. MarketBeat recorded 13 mentions for LifeMD and 4 mentions for Auna. Auna's average media sentiment score of 0.12 beat LifeMD's score of 0.11 indicating that Auna is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Auna
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeMD
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

35.5% of LifeMD shares are owned by institutional investors. 18.9% of LifeMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

LifeMD beats Auna on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AUNA vs. The Competition

MetricAunaOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$645.69M$659.52M$5.10B$18.03B
Dividend YieldN/AN/A36.92%3.46%
P/E RatioN/A37.17186.2025.98
Price / SalesN/A1.172,297.5910.71
Price / CashN/A67.4035.5819.64
Price / BookN/A41.655.466.09
Net IncomeN/A-$189.18M$105.01M$965.64M
7 Day Performance2.76%-0.51%1.42%1.28%
1 Month Performance14.93%-11.94%3.72%6.40%
1 Year PerformanceN/A22.15%7.93%134.18%

Auna Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
1.1793 of 5 stars
$9.32
+0.2%
$11.60
+24.5%
+372.2%$508.65M$152.55M-13.31207Short Interest ↑
High Trading Volume
TVTX
Travere Therapeutics
2.0771 of 5 stars
$6.30
-4.5%
$16.69
+165.0%
-58.4%$498.51M$145.24M-3.00380Gap Up
EHAB
Enhabit
2.9997 of 5 stars
$8.33
+0.5%
$11.21
+34.6%
-28.7%$494.54M$1.05B-5.1410,800Analyst Upgrade
Analyst Revision
News Coverage
High Trading Volume
TSHA
Taysha Gene Therapies
2.127 of 5 stars
$2.34
-7.5%
$6.88
+193.8%
+348.7%$489.99M$15.45M-3.4952Earnings Report
Analyst Forecast
News Coverage
OFIX
Orthofix Medical
0.7563 of 5 stars
$14.64
+1.0%
$18.00
+23.0%
-17.9%$503.49M$746.64M-3.541,634Gap Down
VYGR
Voyager Therapeutics
4.0468 of 5 stars
$8.44
flat
$19.60
+132.2%
-17.6%$486.23M$250.01M2.73162Analyst Downgrade
Short Interest ↑
Analyst Revision
WGS
GeneDx
1.4802 of 5 stars
$20.75
+2.1%
$18.00
-13.3%
+194.7%$509.91M$202.57M-4.011,000Insider Buying
Positive News
Gap Up
FULC
Fulcrum Therapeutics
3.1274 of 5 stars
$7.47
-0.4%
$13.17
+76.3%
+126.6%$481.69M$2.81M-4.7376Analyst Upgrade
Short Interest ↑
Analyst Revision
News Coverage
KALV
KalVista Pharmaceuticals
4.0522 of 5 stars
$12.08
-0.1%
$25.00
+107.0%
+18.8%$512.17MN/A-3.83118
ALEC
Alector
3.4828 of 5 stars
$5.25
+1.0%
$14.00
+166.7%
-28.8%$512.77M$97.06M-3.39244Short Interest ↑

Related Companies and Tools

This page (NYSE:AUNA) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners